-
1
-
-
0029128720
-
Gender effects in pharmacokinetics and pharmacodynamics
-
Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995;50:222-39.
-
(1995)
Drugs
, vol.50
, pp. 222-239
-
-
Harris, R.Z.1
Benet, L.Z.2
Schwartz, J.B.3
-
3
-
-
0026708362
-
Effect of age and gender on the activity of human hepatic CYP3A
-
Hunt CM, Westerkam WR, Stave GM. Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol 1992;44:275-83.
-
(1992)
Biochem Pharmacol
, vol.44
, pp. 275-283
-
-
Hunt, C.M.1
Westerkam, W.R.2
Stave, G.M.3
-
4
-
-
0025009831
-
Effects of age and gender on in vitro properties of human liver microsomal monooxygenases
-
Schmucker DL, Woodhouse KW, Wang RK, Wynne H, James OF, McManus M, et al. Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther 1990;48:365-74.
-
(1990)
Clin Pharmacol Ther
, vol.48
, pp. 365-374
-
-
Schmucker, D.L.1
Woodhouse, K.W.2
Wang, R.K.3
Wynne, H.4
James, O.F.5
McManus, M.6
-
5
-
-
0028237729
-
Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
-
Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270:414-23.
-
(1994)
J Pharmacol Exp Ther
, vol.270
, pp. 414-423
-
-
Shimada, T.1
Yamazaki, H.2
Mimura, M.3
Inui, Y.4
Guengerich, F.P.5
-
6
-
-
0029128788
-
Age bur not gender selectively affects expression of individual cytochrome P450 proteins in human liver
-
George J, Byth K, Farrell GC. Age bur not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochem Pharmacol 1995;50:727-30.
-
(1995)
Biochem Pharmacol
, vol.50
, pp. 727-730
-
-
George, J.1
Byth, K.2
Farrell, G.C.3
-
7
-
-
0031706585
-
Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam
-
Kashuba AD, Bertino JS Jr, Rocci ML Jr, Kulawy RW, Beck DJ, Nafziger AN. Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam. Clin Pharmacol Ther 1998;64:269-77.
-
(1998)
Clin Pharmacol Ther
, vol.64
, pp. 269-277
-
-
Kashuba, A.D.1
Bertino J.S., Jr.2
Rocci M.L., Jr.3
Kulawy, R.W.4
Beck, D.J.5
Nafziger, A.N.6
-
8
-
-
0030759151
-
Assessment of cytochrome P450 3A4 activity during the menstrual cycle using alfentanil as a noninvasive probe
-
Kharasch ED, Russell M, Garton K, Lentz G, Bowdle TA, Cox K. Assessment of cytochrome P450 3A4 activity during the menstrual cycle using alfentanil as a noninvasive probe. Anesthesiology 1997;87:26-35.
-
(1997)
Anesthesiology
, vol.87
, pp. 26-35
-
-
Kharasch, E.D.1
Russell, M.2
Garton, K.3
Lentz, G.4
Bowdle, T.A.5
Cox, K.6
-
9
-
-
0029028792
-
Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy
-
Wacher VJ, Wu CY, Benet LZ. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog 1995;13:129-34.
-
(1995)
Mol Carcinog
, vol.13
, pp. 129-134
-
-
Wacher, V.J.1
Wu, C.Y.2
Benet, L.Z.3
-
10
-
-
0029616617
-
Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms
-
Schuetz EG, Furuya KN, Schuetz JD. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther 1995;275:1011-8.
-
(1995)
J Pharmacol Exp Ther
, vol.275
, pp. 1011-1018
-
-
Schuetz, E.G.1
Furuya, K.N.2
Schuetz, J.D.3
-
11
-
-
0024556650
-
Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450: Studies in rats and patients
-
Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, Guzelian PS. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450: studies in rats and patients. J Clin Invest 1989;83:688-97.
-
(1989)
J Clin Invest
, vol.83
, pp. 688-697
-
-
Watkins, P.B.1
Murray, S.A.2
Winkelman, L.G.3
Heuman, D.M.4
Wrighton, S.A.5
Guzelian, P.S.6
-
12
-
-
0026545245
-
The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease
-
Lown K, Kolars J, Turgeon K, Merion R, Wrighton SA, Watkins PB. The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease. Clin Pharmacol Ther 1992;51:229-38.
-
(1992)
Clin Pharmacol Ther
, vol.51
, pp. 229-238
-
-
Lown, K.1
Kolars, J.2
Turgeon, K.3
Merion, R.4
Wrighton, S.A.5
Watkins, P.B.6
-
13
-
-
0026732029
-
Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity
-
Watkins PB, Turgeon DK, Saenger P, Lown KS, Kolars JC, Hamilton T, et al. Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity. Clin Pharmacol Ther 1992;52:265-73.
-
(1992)
Clin Pharmacol Ther
, vol.52
, pp. 265-273
-
-
Watkins, P.B.1
Turgeon, D.K.2
Saenger, P.3
Lown, K.S.4
Kolars, J.C.5
Hamilton, T.6
-
14
-
-
0007204117
-
Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A
-
Kinirons MT, O'Shea D, Kim RB, Groopman JD, Thummel KE, Wood AJ, et al. Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A. Clin Pharmacol Ther 1999;66:224-31.
-
(1999)
Clin Pharmacol Ther
, vol.66
, pp. 224-231
-
-
Kinirons, M.T.1
O'Shea, D.2
Kim, R.B.3
Groopman, J.D.4
Thummel, K.E.5
Wood, A.J.6
-
15
-
-
0031850954
-
Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a)pyrene
-
Schuetz EG, Yasuda K, Arimori K, Schuetz JD. Human MDR1 and mouse mdr1a P-glycoprotein alter the cellular retention and disposition of erythromycin, but not of retinoic acid or benzo(a)pyrene. Arch Biochem Biophys 1998;350:340-7.
-
(1998)
Arch Biochem Biophys
, vol.350
, pp. 340-347
-
-
Schuetz, E.G.1
Yasuda, K.2
Arimori, K.3
Schuetz, J.D.4
-
16
-
-
0032907322
-
Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein
-
Kim RB, Wandel C, Leake B, Cvetkovic M, Fromm MF, Dempsey PJ, et al. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. Pharm Res 1999;16:408-14.
-
(1999)
Pharm Res
, vol.16
, pp. 408-414
-
-
Kim, R.B.1
Wandel, C.2
Leake, B.3
Cvetkovic, M.4
Fromm, M.F.5
Dempsey, P.J.6
-
17
-
-
0021192084
-
Effect of age, gender, and obesity on midazolam kinetics
-
Greenblatt DJ, Abernethy DR, Locniskar A, Harmatz JS, Limjuco RA, Shader RI. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984;61:27-35.
-
(1984)
Anesthesiology
, vol.61
, pp. 27-35
-
-
Greenblatt, D.J.1
Abernethy, D.R.2
Locniskar, A.3
Harmatz, J.S.4
Limjuco, R.A.5
Shader, R.I.6
-
18
-
-
0030015297
-
Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism
-
Thummel KE, O'Shea D, Paine MF, Shen DD, Kunze KL, Perkins JD, et al. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism. Clin Pharmacol Ther 1996;59:491-502.
-
(1996)
Clin Pharmacol Ther
, vol.59
, pp. 491-502
-
-
Thummel, K.E.1
O'Shea, D.2
Paine, M.F.3
Shen, D.D.4
Kunze, K.L.5
Perkins, J.D.6
-
19
-
-
0031696409
-
The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin
-
Gorski JC, Jones DR, Haehner-Daniels BD, Hamman MA, O'Mara EM Jr, Hall SD. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. Clin Pharmacol Ther 1998;64:133-43.
-
(1998)
Clin Pharmacol Ther
, vol.64
, pp. 133-143
-
-
Gorski, J.C.1
Jones, D.R.2
Haehner-Daniels, B.D.3
Hamman, M.A.4
O'Mara E.M., Jr.5
Hall, S.D.6
-
20
-
-
0028847788
-
The erythromycin breath test predicts the clearance of midazolam
-
Lown KS, Thummel KE, Benedict PE, Shen DD, Turgeon DK, Berent S, et al. The erythromycin breath test predicts the clearance of midazolam. Clin Pharmacol Ther 1995;57:16-24.
-
(1995)
Clin Pharmacol Ther
, vol.57
, pp. 16-24
-
-
Lown, K.S.1
Thummel, K.E.2
Benedict, P.E.3
Shen, D.D.4
Turgeon, D.K.5
Berent, S.6
-
21
-
-
0022646256
-
Absence of interaction of cimetidine and ranitidine with intravenous and oral midazolam
-
Greenblatt DJ, Locniskar A, Scavone JM, Blyden GT, Ochs HR, Harmatz JS, et al. Absence of interaction of cimetidine and ranitidine with intravenous and oral midazolam. Anesth Analg 1986;65:176-80.
-
(1986)
Anesth Analg
, vol.65
, pp. 176-180
-
-
Greenblatt, D.J.1
Locniskar, A.2
Scavone, J.M.3
Blyden, G.T.4
Ochs, H.R.5
Harmatz, J.S.6
-
22
-
-
0032700543
-
Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: Effect of ketoconazole
-
Tsunoda SM, Velez RL, von Moltke LL, Greenblatt DJ. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole. Clin Pharmacol Ther 1999;66:461-71.
-
(1999)
Clin Pharmacol Ther
, vol.66
, pp. 461-471
-
-
Tsunoda, S.M.1
Velez, R.L.2
Von Moltke, L.L.3
Greenblatt, D.J.4
-
23
-
-
0024247094
-
Effects of age, gender and oral contraceptives on intramuscular midazolam pharmacokinetics
-
Holazo AA, Winkler MB, Parel IH. Effects of age, gender and oral contraceptives on intramuscular midazolam pharmacokinetics. J Clin Pharmacol 1988;28:1040-5.
-
(1988)
J Clin Pharmacol
, vol.28
, pp. 1040-1045
-
-
Holazo, A.A.1
Winkler, M.B.2
Parel, I.H.3
-
24
-
-
0031445547
-
Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism
-
Paine MF, Khalighi M, Fisher JM, Shen DD, Kunze KL, Marsh CL, et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther 1997;283:1552-62.
-
(1997)
J Pharmacol Exp Ther
, vol.283
, pp. 1552-1562
-
-
Paine, M.F.1
Khalighi, M.2
Fisher, J.M.3
Shen, D.D.4
Kunze, K.L.5
Marsh, C.L.6
-
25
-
-
12644272784
-
Role of intestinal P-glycoprotein (MDRI) in interpatient variation in the oral bioavailability of cyclosporine
-
Lown KS, Mayo RR, Leichtman AB, Hsiao HL, Turgeon DK, Schmiedlin-Ren P, et al. Role of intestinal P-glycoprotein (MDRI) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 1997;62:248-60.
-
(1997)
Clin Pharmacol Ther
, vol.62
, pp. 248-260
-
-
Lown, K.S.1
Mayo, R.R.2
Leichtman, A.B.3
Hsiao, H.L.4
Turgeon, D.K.5
Schmiedlin-Ren, P.6
-
26
-
-
0028113492
-
Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel: Lack of prediction by the erythromycin breath test
-
Lown KS, Kolars JC, Thummel KE, Barnett JL, Kunze KL, Wrighton SA, et al. Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel: lack of prediction by the erythromycin breath test. Drug Metab Dispos 1994;22:947-55.
-
(1994)
Drug Metab Dispos
, vol.22
, pp. 947-955
-
-
Lown, K.S.1
Kolars, J.C.2
Thummel, K.E.3
Barnett, J.L.4
Kunze, K.L.5
Wrighton, S.A.6
-
27
-
-
0029788148
-
Are cytochrome P450 3A enzymes in the small intestine responsible for different cyclosporine metabolite patterns in stable male and female renal allograft recipients after co-administration of diltiazem?
-
Christians U, Bleck JS, Lampen A, Bader A, Thiesemann C, Kliem V, et al. Are cytochrome P450 3A enzymes in the small intestine responsible for different cyclosporine metabolite patterns in stable male and female renal allograft recipients after co-administration of diltiazem? Transplant Proc 1996;28:2159-61.
-
(1996)
Transplant Proc
, vol.28
, pp. 2159-2161
-
-
Christians, U.1
Bleck, J.S.2
Lampen, A.3
Bader, A.4
Thiesemann, C.5
Kliem, V.6
-
28
-
-
0024449848
-
Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia
-
Horio M, Chin KV, Currier S J, Goldenberg S, Williams C, Pastan I, et al. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia. J Biol Chem 1989;264:14880-4.
-
(1989)
J Biol Chem
, vol.264
, pp. 14880-14884
-
-
Horio, M.1
Chin, K.V.2
Currier, S.J.3
Goldenberg, S.4
Williams, C.5
Pastan, I.6
-
29
-
-
0031843013
-
Multidrug resistance and its reversal
-
Volm M. Multidrug resistance and its reversal. Anticancer Res 1998;18:2905-17.
-
(1998)
Anticancer Res
, vol.18
, pp. 2905-2917
-
-
Volm, M.1
-
30
-
-
0028357260
-
Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics
-
Schwartz JB, Capili H, Daugherty J. Aging of women alters S-verapamil pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 1994;55:509-17.
-
(1994)
Clin Pharmacol Ther
, vol.55
, pp. 509-517
-
-
Schwartz, J.B.1
Capili, H.2
Daugherty, J.3
-
31
-
-
0034145948
-
Gender-specific effects on verapamil pharmacokinetics and pharmacodynamics in humans
-
Krecic-Shepard ME, Barnas CR, Slimko J, Jones MP, Schwartz JB. Gender-specific effects on verapamil pharmacokinetics and pharmacodynamics in humans. J Clin Pharmacol 2000;40:219-30.
-
(2000)
J Clin Pharmacol
, vol.40
, pp. 219-230
-
-
Krecic-Shepard, M.E.1
Barnas, C.R.2
Slimko, J.3
Jones, M.P.4
Schwartz, J.B.5
-
32
-
-
0028110117
-
Verapamil stereoisomers during racemic verapamil administration: Effects of aging and comparisons to administration of individual stereoisomers
-
Schwartz JB, Capili H, Wainer IW. Verapamil stereoisomers during racemic verapamil administration: effects of aging and comparisons to administration of individual stereoisomers. Clin Pharmacol Ther 1994;56:368-76.
-
(1994)
Clin Pharmacol Ther
, vol.56
, pp. 368-376
-
-
Schwartz, J.B.1
Capili, H.2
Wainer, I.W.3
-
33
-
-
0032907609
-
Chronopharmacology of intravenous and oral modified release verapamil
-
Dilger K, Eckhardt K, Hofmann U, Kucher K, Mikus G, Eichelbaum M. Chronopharmacology of intravenous and oral modified release verapamil. Br J Clin Pharmacol 1999;47:413-9.
-
(1999)
Br J Clin Pharmacol
, vol.47
, pp. 413-419
-
-
Dilger, K.1
Eckhardt, K.2
Hofmann, U.3
Kucher, K.4
Mikus, G.5
Eichelbaum, M.6
-
34
-
-
0027420653
-
The effects of age and gender on the stereoselective pharmacokinetics of verapamil
-
Sasaki M, Tateishi T, Ebihara A. The effects of age and gender on the stereoselective pharmacokinetics of verapamil. Clin Pharmacol Ther 1993;54:278-85.
-
(1993)
Clin Pharmacol Ther
, vol.54
, pp. 278-285
-
-
Sasaki, M.1
Tateishi, T.2
Ebihara, A.3
-
35
-
-
0028848415
-
Age and gender related changes in stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil
-
Gupta SK, Atkinson L, Tu T, Longstreth JA. Age and gender related changes in stereoselective pharmacokinetics and pharmacodynamics of verapamil and norverapamil. Br J Clin Pharmacol 1995;40:325-31.
-
(1995)
Br J Clin Pharmacol
, vol.40
, pp. 325-331
-
-
Gupta, S.K.1
Atkinson, L.2
Tu, T.3
Longstreth, J.A.4
-
36
-
-
0033833913
-
Faster clearance of sustained release verapamil in men versus women: Continuing observations on sex-specific differences after oral administration of verapamil
-
Krecic-Shepard ME, Barnas CR, Slimko J, Schwartz JB. Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil. Clin Pharmacol Ther 2000;68:286-92.
-
(2000)
Clin Pharmacol Ther
, vol.68
, pp. 286-292
-
-
Krecic-Shepard, M.E.1
Barnas, C.R.2
Slimko, J.3
Schwartz, J.B.4
-
37
-
-
0034807802
-
Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate
-
Cummins CL, Mangravite LM, Benet LZ. Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Pharm Res 2001;18:1102-9.
-
(2001)
Pharm Res
, vol.18
, pp. 1102-1109
-
-
Cummins, C.L.1
Mangravite, L.M.2
Benet, L.Z.3
-
38
-
-
0036175307
-
Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4
-
Cummins CL, Jacobsen W, Benet LZ. Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 2002;300:1036-45.
-
(2002)
J Pharmacol Exp Ther
, vol.300
, pp. 1036-1045
-
-
Cummins, C.L.1
Jacobsen, W.2
Benet, L.Z.3
-
40
-
-
0033795486
-
Potential role of P-glycoprotein in affecting hepatic metabolism of drugs
-
Chiou WL, Chung SM, Wu TC. Potential role of P-glycoprotein in affecting hepatic metabolism of drugs. Pharm Res 2000;17:903-5.
-
(2000)
Pharm Res
, vol.17
, pp. 903-905
-
-
Chiou, W.L.1
Chung, S.M.2
Wu, T.C.3
-
41
-
-
0032807119
-
P-glycoprotein-dependent disposition kinetics of tacrolimus: Studies in mdr1a knockout mice
-
Yokogawa K, Takahashi M, Tamai I, Konishi H, Nomura M, Moritani S, et al. P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice. Pharm Res 1999;16:1213-8.
-
(1999)
Pharm Res
, vol.16
, pp. 1213-1218
-
-
Yokogawa, K.1
Takahashi, M.2
Tamai, I.3
Konishi, H.4
Nomura, M.5
Moritani, S.6
-
42
-
-
12644278301
-
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
-
Sparreboom A, van Asperen J, Mayer U, Schinkel AH, Smit JW, Meijer DK, et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc Natl Acad Sci USA 1997;94:2031-5.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 2031-2035
-
-
Sparreboom, A.1
Van Asperen, J.2
Mayer, U.3
Schinkel, A.H.4
Smit, J.W.5
Meijer, D.K.6
-
43
-
-
0029952418
-
Altered pharmacokinetics of vinblastine in mdr1a P-glycoprotein-deficient mice
-
van Asperen J, Schinkel AH, Beijnen JH, Nooijen WJ, Borst P, van Tellingen O. Altered pharmacokinetics of vinblastine in mdr1a P-glycoprotein-deficient mice. J Natl Cancer Inst 1996;88:994-9.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 994-999
-
-
Van Asperen, J.1
Schinkel, A.H.2
Beijnen, J.H.3
Nooijen, W.J.4
Borst, P.5
Van Tellingen, O.6
-
44
-
-
0034105897
-
The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice
-
van Asperen J, van Tellingen O, Beijnen JH. The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice. Drug Metab Dispos 2000;28:264-7.
-
(2000)
Drug Metab Dispos
, vol.28
, pp. 264-267
-
-
Van Asperen, J.1
Van Tellingen, O.2
Beijnen, J.H.3
-
45
-
-
0030781139
-
Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833
-
Mayer U, Wagenaar E, Dorobek B, Beijnen JH, Borst P, Schinkel AH. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J Clin Invest 1997;100:2430-6.
-
(1997)
J Clin Invest
, vol.100
, pp. 2430-2436
-
-
Mayer, U.1
Wagenaar, E.2
Dorobek, B.3
Beijnen, J.H.4
Borst, P.5
Schinkel, A.H.6
-
46
-
-
0034750648
-
Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization
-
Chiou WL, Jeong HY, Wu TC, Ma C. Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization. Clin Pharmacol Ther 2001;70:305-10.
-
(2001)
Clin Pharmacol Ther
, vol.70
, pp. 305-310
-
-
Chiou, W.L.1
Jeong, H.Y.2
Wu, T.C.3
Ma, C.4
-
47
-
-
0028229150
-
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
-
Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994;77:491-502.
-
(1994)
Cell
, vol.77
, pp. 491-502
-
-
Schinkel, A.H.1
Smit, J.J.2
Van Tellingen, O.3
Beijnen, J.H.4
Wagenaar, E.5
Van Deemter, L.6
-
48
-
-
0033984216
-
Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes
-
Schuetz EG, Umbenhauer DR, Yasuda K, Brimer C, Nguyen L, Relling MV, et al. Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes. Mol Pharmacol 2000; 57:188-97.
-
(2000)
Mol Pharmacol
, vol.57
, pp. 188-197
-
-
Schuetz, E.G.1
Umbenhauer, D.R.2
Yasuda, K.3
Brimer, C.4
Nguyen, L.5
Relling, M.V.6
-
49
-
-
0025202858
-
Influence of age on the pharmacokinetics of alfentanil. Gender dependence
-
Lemmens HJ, Burm AG, Hennis PJ, Gladines MP, Bovill JG. Influence of age on the pharmacokinetics of alfentanil. Gender dependence [see comments]. Clin Pharmacokinet 1990;19:416-22.
-
(1990)
Clin Pharmacokinet
, vol.19
, pp. 416-422
-
-
Lemmens, H.J.1
Burm, A.G.2
Hennis, P.J.3
Gladines, M.P.4
Bovill, J.G.5
-
50
-
-
0024542703
-
Aging and alfentanil disposition in healthy volunteers and surgical patients
-
Sitar DS, Duke PC, Benthuysen JL, Sanford TJ, Smith NT. Aging and alfentanil disposition in healthy volunteers and surgical patients. Can J Anaesth 1989;36:149-54.
-
(1989)
Can J Anaesth
, vol.36
, pp. 149-154
-
-
Sitar, D.S.1
Duke, P.C.2
Benthuysen, J.L.3
Sanford, T.J.4
Smith, N.T.5
-
51
-
-
0030868233
-
The role of cytochrome P450 3A4 in alfentanil clearance: Implications for interindividual variability in disposition and perioperative drug interactions
-
Kharasch ED, Russell M, Mautz D, Thummel KE, Kunze KL, Bowdle A, et al. The role of cytochrome P450 3A4 in alfentanil clearance: implications for interindividual variability in disposition and perioperative drug interactions. Anesthesiology 1997;87:36-50.
-
(1997)
Anesthesiology
, vol.87
, pp. 36-50
-
-
Kharasch, E.D.1
Russell, M.2
Mautz, D.3
Thummel, K.E.4
Kunze, K.L.5
Bowdle, A.6
-
52
-
-
0030005053
-
Effect of age and gender on pharmacokinetics of atorvastatin in humans
-
Gibson DM, Bron NJ, Richens A, Hounslow NJ, Sedman AJ, Whitfield LR. Effect of age and gender on pharmacokinetics of atorvastatin in humans. J Clin Pharmacol 1996;36:242-6.
-
(1996)
J Clin Pharmacol
, vol.36
, pp. 242-246
-
-
Gibson, D.M.1
Bron, N.J.2
Richens, A.3
Hounslow, N.J.4
Sedman, A.J.5
Whitfield, L.R.6
-
53
-
-
0034921923
-
A comparative multidose pharmacokinetic study of buspirone extended-release tablets with a reference immediate-release product
-
Sakr A, Andheria M. A comparative multidose pharmacokinetic study of buspirone extended-release tablets with a reference immediate-release product. J Clin Pharmacol 2001;41:886-94.
-
(2001)
J Clin Pharmacol
, vol.41
, pp. 886-894
-
-
Sakr, A.1
Andheria, M.2
-
54
-
-
0034464614
-
Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults
-
Isaacsohn J, Zinny M, Mazzu A, Lettieri J, Heller AH. Influence of gender on the pharmacokinetics, safety, and tolerability of cerivastatin in healthy adults. Eur J Clin Pharmacol 2001;56:897-903.
-
(2001)
Eur J Clin Pharmacol
, vol.56
, pp. 897-903
-
-
Isaacsohn, J.1
Zinny, M.2
Mazzu, A.3
Lettieri, J.4
Heller, A.H.5
-
55
-
-
0022651554
-
Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay
-
Kahan BD, Kramer WG, Wideman C, Flechner SM, Lorber MI, Van Buren CT. Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay. Transplantation 1986;41:459-64.
-
(1986)
Transplantation
, vol.41
, pp. 459-464
-
-
Kahan, B.D.1
Kramer, W.G.2
Wideman, C.3
Flechner, S.M.4
Lorber, M.I.5
Van Buren, C.T.6
-
56
-
-
0033725192
-
Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers
-
Min DI, Lee M, Ku YM, Flanigan M. Gender-dependent racial difference in disposition of cyclosporine among healthy African American and white volunteers. Clin Pharmacol Ther 2000;68:478-86.
-
(2000)
Clin Pharmacol Ther
, vol.68
, pp. 478-486
-
-
Min, D.I.1
Lee, M.2
Ku, Y.M.3
Flanigan, M.4
-
57
-
-
0022515811
-
Age-dependent cyclosporine: Pharmacokinetics in marrow transplant recipients
-
Yee GC, Lennon TP, Gmur DJ, Kennedy MS, Deeg HJ. Age-dependent cyclosporine: pharmacokinetics in marrow transplant recipients. Clin Pharmacol Ther 1986;40:438-43.
-
(1986)
Clin Pharmacol Ther
, vol.40
, pp. 438-443
-
-
Yee, G.C.1
Lennon, T.P.2
Gmur, D.J.3
Kennedy, M.S.4
Deeg, H.J.5
-
58
-
-
0031655411
-
Comparison of two cyclosporine formulations in healthy volunteers: Bioequivalence of the new Sang-35 formulation and Neoral
-
Schroeder TJ, Cho MJ, Pollack GM, Floc'h R, Moran HB, Levy R, et al. Comparison of two cyclosporine formulations in healthy volunteers: Bioequivalence of the new Sang-35 formulation and Neoral. J Clin Pharmacol 1998;38:807-14.
-
(1998)
J Clin Pharmacol
, vol.38
, pp. 807-814
-
-
Schroeder, T.J.1
Cho, M.J.2
Pollack, G.M.3
Floc'h, R.4
Moran, H.B.5
Levy, R.6
-
59
-
-
8944233363
-
Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients
-
Bleck JS, Thiesemann C, Kliem V, Christians U, Hecker H, Repp H, et al. Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients. Br J Clin Pharmacol 1996;41:551-6.
-
(1996)
Br J Clin Pharmacol
, vol.41
, pp. 551-556
-
-
Bleck, J.S.1
Thiesemann, C.2
Kliem, V.3
Christians, U.4
Hecker, H.5
Repp, H.6
-
60
-
-
0019441003
-
Diazepam kinetics in relation to age and sex
-
Ochs HR, Greenblatt DJ, Divoll M, Abernethy DR, Feyerabend H, Dengler HJ. Diazepam kinetics in relation to age and sex. Pharmacology 1981;23:24-30.
-
(1981)
Pharmacology
, vol.23
, pp. 24-30
-
-
Ochs, H.R.1
Greenblatt, D.J.2
Divoll, M.3
Abernethy, D.R.4
Feyerabend, H.5
Dengler, H.J.6
-
62
-
-
0018390686
-
Age- and gender-related differences in diazepam pharmacokinetics
-
MacLeod SM, Giles HG, Bengert B, Liu FF, Sellers EM. Age- and gender-related differences in diazepam pharmacokinetics. J Clin Pharmacol 1979;19:15-9.
-
(1979)
J Clin Pharmacol
, vol.19
, pp. 15-19
-
-
MacLeod, S.M.1
Giles, H.G.2
Bengert, B.3
Liu, F.F.4
Sellers, E.M.5
-
63
-
-
0029014613
-
Gender-related pharmacokinetics of diltiazem in healthy subjects
-
Saenz-Campos D, Bayes MC, Martin S, Barbanoj MJ, Jane F. Gender-related pharmacokinetics of diltiazem in healthy subjects. Int J Clin Pharmacol Ther 1995;33:397-400.
-
(1995)
Int J Clin Pharmacol Ther
, vol.33
, pp. 397-400
-
-
Saenz-Campos, D.1
Bayes, M.C.2
Martin, S.3
Barbanoj, M.J.4
Jane, F.5
-
64
-
-
0027181298
-
Pharmacokinetics and metabolism of diltiazem in healthy males and females following a single oral dose
-
Yeung PK, Prescott C, Haddad C, Montague TJ, McGregor C, Quilliam MA, et al. Pharmacokinetics and metabolism of diltiazem in healthy males and females following a single oral dose. Eur J Drug Metab Pharmacokinet 1993;18:199-206.
-
(1993)
Eur J Drug Metab Pharmacokinet
, vol.18
, pp. 199-206
-
-
Yeung, P.K.1
Prescott, C.2
Haddad, C.3
Montague, T.J.4
McGregor, C.5
Quilliam, M.A.6
-
65
-
-
0035102154
-
Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects
-
Rohatagi S, Gillen M, Aubeneau M, Jan C, Pandit B, Jensen BK, et al. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects. Int J Clin Pharmacol Ther 2001 ;39:126-34.
-
(2001)
Int J Clin Pharmacol Ther
, vol.39
, pp. 126-134
-
-
Rohatagi, S.1
Gillen, M.2
Aubeneau, M.3
Jan, C.4
Pandit, B.5
Jensen, B.K.6
-
66
-
-
0032979760
-
Open-label, single-dose pharmacokinetic study of modafinil tablets: Influence of age and gender in normal subjects
-
Wong YN, King SP, Simcoe D, Gorman S, Laughton W, McCormick GC, et al. Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects. J Clin Pharmacol 1999;39:281-8.
-
(1999)
J Clin Pharmacol
, vol.39
, pp. 281-288
-
-
Wong, Y.N.1
King, S.P.2
Simcoe, D.3
Gorman, S.4
Laughton, W.5
McCormick, G.C.6
-
67
-
-
0030450101
-
Effects of gender, age, and face on the pharmacokinetics of etoposide after intravenous administration of etoposide phosphate in cancer patients
-
Kaul S, Srinivas NR, Mummaneni V, Igwemezie LN, Barbhaiya RH. Effects of gender, age, and face on the pharmacokinetics of etoposide after intravenous administration of etoposide phosphate in cancer patients. Semin Oncol 1996;23:23-9.
-
(1996)
Semin Oncol
, vol.23
, pp. 23-29
-
-
Kaul, S.1
Srinivas, N.R.2
Mummaneni, V.3
Igwemezie, L.N.4
Barbhaiya, R.H.5
-
69
-
-
0021215730
-
Lidocaine disposition: Sex differences and effects of cimetidine
-
Wing LM, Miners JO, Birkett DJ, Foenander T, Lillywhite K, Wanwimolruk S. Lidocaine disposition: sex differences and effects of cimetidine. Clin Pharmacol Ther 1984;35:695-701.
-
(1984)
Clin Pharmacol Ther
, vol.35
, pp. 695-701
-
-
Wing, L.M.1
Miners, J.O.2
Birkett, D.J.3
Foenander, T.4
Lillywhite, K.5
Wanwimolruk, S.6
-
70
-
-
0026591839
-
Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin
-
Cheng H, Rogers JD, Sweany AE, Dobrinska MR, Stein EA, Tate AC, et al. Influence of age and gender on the plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitory activity following multiple doses of lovastatin and simvastatin. Pharm Res 1992;9:1629-33.
-
(1992)
Pharm Res
, vol.9
, pp. 1629-1633
-
-
Cheng, H.1
Rogers, J.D.2
Sweany, A.E.3
Dobrinska, M.R.4
Stein, E.A.5
Tate, A.C.6
-
71
-
-
0029132157
-
Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts
-
de Vos JW, Geerlings PJ, van den Brink W, Ufkes JG, van Wilgenburg H. Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts. Eur J Clin Pharmacol 1995;48:361-6.
-
(1995)
Eur J Clin Pharmacol
, vol.48
, pp. 361-366
-
-
De Vos, J.W.1
Geerlings, P.J.2
Van Den Brink, W.3
Ufkes, J.G.4
Van Wilgenburg, H.5
-
72
-
-
0027365895
-
Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics
-
Lew KH, Ludwig EA, Milad MA, Donovan K, Middleton E Jr, Ferry JJ, et al. Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther 1993;54:402-14.
-
(1993)
Clin Pharmacol Ther
, vol.54
, pp. 402-414
-
-
Lew, K.H.1
Ludwig, E.A.2
Milad, M.A.3
Donovan, K.4
Middleton E., Jr.5
Ferry, J.J.6
-
73
-
-
0030023969
-
A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses
-
Barbhaiya RH, Buch AB, Greene DS. A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses. J Clin Psychopharmacol 1996;16:19-25.
-
(1996)
J Clin Psychopharmacol
, vol.16
, pp. 19-25
-
-
Barbhaiya, R.H.1
Buch, A.B.2
Greene, D.S.3
-
74
-
-
0022656690
-
The intra- and inter-subject variability of nifedipine pharmacokinetics in young volunteers
-
Lobo J, Jack DB, Kendall MJ. The intra- and inter-subject variability of nifedipine pharmacokinetics in young volunteers. Eur J Clin Pharmacol 1986;30:57-60.
-
(1986)
Eur J Clin Pharmacol
, vol.30
, pp. 57-60
-
-
Lobo, J.1
Jack, D.B.2
Kendall, M.J.3
-
75
-
-
0033842115
-
Race and sex influence clearance of nifedipine: Results of a population study
-
Krecic-Shepard ME, Park K, Barnas C, Slimko J, Kerwin DR, Schwartz JB. Race and sex influence clearance of nifedipine: results of a population study. Clin Pharmacol Ther 2000;68:130-42.
-
(2000)
Clin Pharmacol Ther
, vol.68
, pp. 130-142
-
-
Krecic-Shepard, M.E.1
Park, K.2
Barnas, C.3
Slimko, J.4
Kerwin, D.R.5
Schwartz, J.B.6
-
76
-
-
0032918379
-
Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6)
-
Desta Z, Kerbusch T, Flockhart DA. Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6). Clin Pharmacol Ther 1999;65:10-20.
-
(1999)
Clin Pharmacol Ther
, vol.65
, pp. 10-20
-
-
Desta, Z.1
Kerbusch, T.2
Flockhart, D.A.3
-
77
-
-
0020684914
-
Prednisolone disposition and protein binding in oral contraceptive users
-
Boekenoogen SJ, Szefler SJ, Jusko WJ. Prednisolone disposition and protein binding in oral contraceptive users. J Clin Endocrinol Metab 1983;56:702-9.
-
(1983)
J Clin Endocrinol Metab
, vol.56
, pp. 702-709
-
-
Boekenoogen, S.J.1
Szefler, S.J.2
Jusko, W.J.3
-
78
-
-
0021222832
-
Alterations in prednisolone disposition as a result of time of administration, gender and dose
-
Meffin PJ, Brooks PM, Sallustio BC. Alterations in prednisolone disposition as a result of time of administration, gender and dose. Br J Clin Pharmacol 1984;17:395-404.
-
(1984)
Br J Clin Pharmacol
, vol.17
, pp. 395-404
-
-
Meffin, P.J.1
Brooks, P.M.2
Sallustio, B.C.3
-
79
-
-
0034770387
-
Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race
-
Magee MH, Blum RA, Lates CD, Jusko WJ. Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race. J Clin Pharmacol 2001;41:1180-94.
-
(2001)
J Clin Pharmacol
, vol.41
, pp. 1180-1194
-
-
Magee, M.H.1
Blum, R.A.2
Lates, C.D.3
Jusko, W.J.4
-
80
-
-
0002995379
-
The effect of gender on ketoconazole induced changes in tacrolimus pharmacokinetics
-
1999 May 15-19; Chicago, Illinois. Chicago: The Society
-
Tuteja S, Alloway RR, Meier-Kriesche HU, Streetman DS, Johnson JA, Gaber AO. The effect of gender on ketoconazole induced changes in tacrolimus pharmacokinetics (abstract). In: Proceedings of the Eighteenth Annual Meeting of the American Society of Transplantation; 1999 May 15-19; Chicago, Illinois. Chicago: The Society; 1999. S163.
-
(1999)
Proceedings of the Eighteenth Annual Meeting of the American Society of Transplantation
-
-
Tuteja, S.1
Alloway, R.R.2
Meier-Kriesche, H.U.3
Streetman, D.S.4
Johnson, J.A.5
Gaber, A.O.6
-
81
-
-
0028356191
-
Effect of age and gender on tirilazad pharmacokinetics in humans
-
Hulst LK, Fleishaker JC, Peters GR, Harry JD, Wright DM, Ward P. Effect of age and gender on tirilazad pharmacokinetics in humans. Clin Pharmacol Ther 1994;55:378-84.
-
(1994)
Clin Pharmacol Ther
, vol.55
, pp. 378-384
-
-
Hulst, L.K.1
Fleishaker, J.C.2
Peters, G.R.3
Harry, J.D.4
Wright, D.M.5
Ward, P.6
-
82
-
-
0029878029
-
Gender does not affect the degree of induction of tirilazad clearance by phenobarbital
-
Fleishaker JC, Pearson LK, Peters GR. Gender does not affect the degree of induction of tirilazad clearance by phenobarbital. Eur J Clin Pharmacol 1996;50:139-45.
-
(1996)
Eur J Clin Pharmacol
, vol.50
, pp. 139-145
-
-
Fleishaker, J.C.1
Pearson, L.K.2
Peters, G.R.3
-
83
-
-
0029761817
-
Pharmacokinetics of tirilazad and U-89678 in ischemic stroke patients receiving a loading regimen and maintenance regimen of 10 mg/kg/day of tirilazad
-
Fleishaker JC, Peters GR. Pharmacokinetics of tirilazad and U-89678 in ischemic stroke patients receiving a loading regimen and maintenance regimen of 10 mg/kg/day of tirilazad. J Clin Pharmacol 1996;36:809-13.
-
(1996)
J Clin Pharmacol
, vol.36
, pp. 809-813
-
-
Fleishaker, J.C.1
Peters, G.R.2
-
84
-
-
0023197591
-
Trazodone kinetics: Effect of age, gender, and obesity
-
Greenblatt DJ, Friedman H, Burstein ES, Scavone JM, Blyden GT, Ochs HR, et al. Trazodone kinetics: effect of age, gender, and obesity. Clin Pharmacol Ther 1987;42:193-200.
-
(1987)
Clin Pharmacol Ther
, vol.42
, pp. 193-200
-
-
Greenblatt, D.J.1
Friedman, H.2
Burstein, E.S.3
Scavone, J.M.4
Blyden, G.T.5
Ochs, H.R.6
-
86
-
-
0020659138
-
Reduced clearance of triazolam in old age: Relation to antipyrine oxidizing capacity
-
Greenblatt DJ, Divoll M, Abernethy DR, Moschitto LJ, Smith RB, Shader RI. Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity. Br J Clin Pharmacol 1983;15:303-9.
-
(1983)
Br J Clin Pharmacol
, vol.15
, pp. 303-309
-
-
Greenblatt, D.J.1
Divoll, M.2
Abernethy, D.R.3
Moschitto, L.J.4
Smith, R.B.5
Shader, R.I.6
-
87
-
-
0027931014
-
Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: Kinetic-dynamic studies
-
Greenblatt DJ, Harmatz JS, Gouthro TA, Locke J, Shader RI. Distinguishing a benzodiazepine agonist (triazolam) from a nonagonist anxiolytic (buspirone) by electroencephalography: kinetic-dynamic studies. Clin Pharmacol Ther 1994;56:100-11.
-
(1994)
Clin Pharmacol Ther
, vol.56
, pp. 100-111
-
-
Greenblatt, D.J.1
Harmatz, J.S.2
Gouthro, T.A.3
Locke, J.4
Shader, R.I.5
-
88
-
-
0034099053
-
Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: Evaluation of sex-dependent differences
-
Greenblatt DJ, Harmatz JS, von Moltke LL, Wright CE, Durol AL, Harrel-Joseph LM, et al. Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences. J Pharmacol Exp Ther 2000;293:435-43.
-
(2000)
J Pharmacol Exp Ther
, vol.293
, pp. 435-443
-
-
Greenblatt, D.J.1
Harmatz, J.S.2
Von Moltke, L.L.3
Wright, C.E.4
Durol, A.L.5
Harrel-Joseph, L.M.6
-
89
-
-
0026514189
-
Age and gender effects on ondansetron pharmacokinetics: Evaluation of healthy aged volunteers
-
Pritchard JF, Bryson JC, Kernodle AE, Benedetti TL, Powell JR. Age and gender effects on ondansetron pharmacokinetics: evaluation of healthy aged volunteers. Clin Pharmacol Ther 1992;51:51-5.
-
(1992)
Clin Pharmacol Ther
, vol.51
, pp. 51-55
-
-
Pritchard, J.F.1
Bryson, J.C.2
Kernodle, A.E.3
Benedetti, T.L.4
Powell, J.R.5
-
90
-
-
0028954282
-
Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects
-
Shah A, Lettieri J, Nix D, Wilton J, Heller AH. Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects. Antimicrob Agents Chemother 1995;39:1003-6.
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 1003-1006
-
-
Shah, A.1
Lettieri, J.2
Nix, D.3
Wilton, J.4
Heller, A.H.5
-
92
-
-
0013429878
-
Erythromycin breath test (ERMBT): A basis for sex differences and lack of effect of CYP3A5 expression and MDR1 genotypes
-
Kashuba ADM, Reddy SY, Paine MF, Schuetz EG, Lamba J, Dhakhwa S, et al. Erythromycin breath test (ERMBT): a basis for sex differences and lack of effect of CYP3A5 expression and MDR1 genotypes (abstract). Drug Metab Rev 2001;33 (Suppl 1):95.
-
(2001)
Drug Metab Rev
, vol.33
, Issue.SUPPL. 1
, pp. 95
-
-
Kashuba, A.D.M.1
Reddy, S.Y.2
Paine, M.F.3
Schuetz, E.G.4
Lamba, J.5
Dhakhwa, S.6
-
93
-
-
0018868749
-
Intersubject and dose-related variability after intravenous administration of erythromycin
-
Austin KL, Mather LE, Philpot CR, McDonald PJ. Intersubject and dose-related variability after intravenous administration of erythromycin. Br J Clin Pharmacol 1980;10:273-9.
-
(1980)
Br J Clin Pharmacol
, vol.10
, pp. 273-279
-
-
Austin, K.L.1
Mather, L.E.2
Philpot, C.R.3
McDonald, P.J.4
-
94
-
-
0035051735
-
Gender differences in the disposition of metronidazole
-
Carcas AJ, Guerra P, Frias J, Soto A, Fernandez-Aijon A, Montuenga C, et al. Gender differences in the disposition of metronidazole. Int J Clin Pharmacol Ther 2001;39:213-8.
-
(2001)
Int J Clin Pharmacol Ther
, vol.39
, pp. 213-218
-
-
Carcas, A.J.1
Guerra, P.2
Frias, J.3
Soto, A.4
Fernandez-Aijon, A.5
Montuenga, C.6
-
95
-
-
0033008214
-
Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle
-
Mendelson JH, Mello NK, Sholar MB, Siegel AJ, Kaufman MJ, Levin JM, et al. Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology 1999;21:294-303.
-
(1999)
Neuropsychopharmacology
, vol.21
, pp. 294-303
-
-
Mendelson, J.H.1
Mello, N.K.2
Sholar, M.B.3
Siegel, A.J.4
Kaufman, M.J.5
Levin, J.M.6
-
96
-
-
0025947778
-
Influence of menstrual cycle and gender on alprazolam pharmacokinetics
-
Kirkwood C, Moore A, Hayes P, DeVane CL, Pelonero A. Influence of menstrual cycle and gender on alprazolam pharmacokinetics. Clin Pharmacol Ther 1991;50:404-9.
-
(1991)
Clin Pharmacol Ther
, vol.50
, pp. 404-409
-
-
Kirkwood, C.1
Moore, A.2
Hayes, P.3
DeVane, C.L.4
Pelonero, A.5
-
97
-
-
0020699738
-
Alprazolam kinetics in the elderly: Relation to antipyrine disposition
-
Greenblatt DJ, Divoll M, Abernethy DR, Moschitto LJ, Smith RB, Shader RI. Alprazolam kinetics in the elderly: relation to antipyrine disposition. Arch Gen Psychiatry 1983;40:287-90.
-
(1983)
Arch Gen Psychiatry
, vol.40
, pp. 287-290
-
-
Greenblatt, D.J.1
Divoll, M.2
Abernethy, D.R.3
Moschitto, L.J.4
Smith, R.B.5
Shader, R.I.6
-
98
-
-
0026345139
-
Disposition of alprazolam in human volunteers: Differences between genders
-
Kristjansson F, Thorsteinsson SB. Disposition of alprazolam in human volunteers: differences between genders. Acta Pharm Nord 1991;3:249-50.
-
(1991)
Acta Pharm Nord
, vol.3
, pp. 249-250
-
-
Kristjansson, F.1
Thorsteinsson, S.B.2
-
99
-
-
0035071598
-
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
-
Kuehl P, Zhang J, Lin Y, Lamba J, Assem M, Schuetz J, et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 2001;27:383-91.
-
(2001)
Nat Genet
, vol.27
, pp. 383-391
-
-
Kuehl, P.1
Zhang, J.2
Lin, Y.3
Lamba, J.4
Assem, M.5
Schuetz, J.6
-
100
-
-
0032793959
-
OATP P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine
-
Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 1999;27:866-71.
-
(1999)
Drug Metab Dispos
, vol.27
, pp. 866-871
-
-
Cvetkovic, M.1
Leake, B.2
Fromm, M.F.3
Wilkinson, G.R.4
Kim, R.B.5
-
101
-
-
13344261979
-
Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in Eutope, Australia, and New Zealand
-
Kassell NF, Haley EC Jr, Apperson-Hansen C, Alves WM. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Eutope, Australia, and New Zealand. J Neurosurg 1996; 84:221-8.
-
(1996)
J Neurosurg
, vol.84
, pp. 221-228
-
-
Kassell, N.F.1
Haley E.C., Jr.2
Apperson-Hansen, C.3
Alves, W.M.4
-
102
-
-
0036290013
-
How important are gender differences in pharmacokinetics?
-
Meibohm B, Beierle I, Derendorf H. How important are gender differences in pharmacokinetics? Clin Pharmacokinet 2002;41:329-42.
-
(2002)
Clin Pharmacokinet
, vol.41
, pp. 329-342
-
-
Meibohm, B.1
Beierle, I.2
Derendorf, H.3
|